Screener
Theravance Biopharma TBPH Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $835.73M.
The source filing: Theravance Biopharma’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 9:00 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001104659-26-056760
FAQ
- What is Theravance Biopharma's market capitalization?
- Theravance Biopharma (TBPH) reported market capitalization of $835.73M in Q1 2026.
- How has Theravance Biopharma's market capitalization changed year-over-year?
- Theravance Biopharma's market capitalization increased by 89.2% year-over-year, from $441.77M to $835.73M.
- What is the long-term trend for Theravance Biopharma's market capitalization?
- Over 5 years (2020 to 2025), Theravance Biopharma's market capitalization has grown at a -3.7% compound annual growth rate (CAGR), from $1.15B to $948.08M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Theravance Biopharma's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude